687 - Examination of Risk of Adverse Neurodevelopmental Outcomes among Infants Born During the COVID-19 Pandemic

Rebecca J.. Baer, UCSF, San Francisco, CA, United States; Scott P. Oltman, University of California, San Francisco, School of Medicine, San Francisco, CA, United States; Carrie Des Roches, University of California, Berkeley, Castro Valley, CA, United States; Audrey Lyndon, NYU Rory Meyers College of Nursing, New York, NY, United States; Safyer McKenzie-Sampson, Stanford University School of Medicine, Palo Alto, CA, United States; Larry Rand, University of California, San Francisco, School of Medicine, San Francisco, CA, United States; Kelli K. Ryckman, Indiana University, Bloomington, IN, United States; Akila Subramaniam, University of Alabama School of Medicine, Birmingham, AL, United States; Louie M. Swander, University of California, San Francisco, School of Medicine, San Francisco, CA, United States; Laura Jelliffe-Pawlowski, New York University, New York, NY, United States; Elizabeth E. Rogers, University of California, San Francisco, School of Medicine, San Francisco, CA, United States